Hunan Warrant Pharmaceutical Co.,Ltd (SHA:688799)

SHA:688799 Revenue

Hunan Warrant Pharmaceutical Co.,Ltd had revenue of 305.88M CNY in the quarter ending September 30, 2026, a decrease of -17.80%. This brings the company's total for the last twelve months to 1.38B, down -3.11% year-over-year. In the year 2025, Hunan Warrant Pharmaceutical Co.,Ltd had annual revenue of 1.50B with 6.46% growth. That makes Hunan Warrant Pharmaceutical Co.,Ltd the 17,232nd largest company in the world by revenue and 3,141st in China.

• Revenue (ttm): 1.38B
• Revenue Growth: -3.11%
• P/S Ratio: 4.49
• Revenue / Employee: 1.04M
• Employees: 1,329
• Market Cap: 6.22B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• East China 632.53M 43.8%
• Central China 193.35M 13.4%
• Southwest 185.70M 12.9%
• North China 168.44M 11.7%
• South China 159.53M 11.0%
• Northwestern 52.97M 3.7%
• Northeast China 41.73M 2.9%
• Overseas 10.61M 0.7%

Fiscal year ended Dec 31, 2025 See the full SHA:688799 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.50B	91.28M	6.46%
Dec 31, 2024	1.41B	-19.84M	-1.38%
Dec 31, 2023	1.43B	140.13M	10.84%
Dec 31, 2022	1.29B	146.06M	12.74%
Dec 31, 2021	1.15B	195.97M	20.61%

Data Source: S&P Global Market Intelligence Last updated: Oct 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 12, 2026

Data Sources Report a data error